These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17725295)

  • 1. [Retinal pigmentary degeneration--clinical features, diagnostics and possibilities of treatment].
    Grześk M; Malukiewicz-Wiśniewska G
    Klin Oczna; 2007; 109(4-6):230-4. PubMed ID: 17725295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early therapeutic trials for retinitis pigmentosa].
    Dufier JL
    Bull Acad Natl Med; 2003; 187(9):1685-92; discussion 1692-4. PubMed ID: 15369238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic study of X-linked cone-rod dystrophy (CORDX1) caused by a mutation in the RPGR exon ORF15.
    Demirci FY; Gupta N; Radak AL; Rigatti BW; Mah TS; Milam AH; Gorin MB
    Am J Ophthalmol; 2005 Feb; 139(2):386-8. PubMed ID: 15734019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of some clinical parameters in patients with retinitis pigmentosa in relationship to the type of inheritance].
    Zalewska R; Midro AT; Stankiewicz A; Mariak Z; Proniewska-Skretek E; Sobolewski P
    Klin Oczna; 1999; 101(1):29-32. PubMed ID: 10401211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review and update: current treatment trends for patients with retinitis pigmentosa.
    Shintani K; Shechtman DL; Gurwood AS
    Optometry; 2009 Jul; 80(7):384-401. PubMed ID: 19545852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?
    Veltel S; Wittinghofer A
    Expert Opin Ther Targets; 2009 Oct; 13(10):1239-51. PubMed ID: 19702441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation screening of the peropsin gene, a retinal pigment epithelium specific rhodopsin homolog, in patients with retinitis pigmentosa and allied diseases.
    Rivolta C; Berson EL; Dryja TP
    Mol Vis; 2006 Dec; 12():1511-5. PubMed ID: 17167409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in pathogenesis and therapeutic research in retinitis pigmentosa and age-related macular degeneration].
    Tamai M
    Nippon Ganka Gakkai Zasshi; 2004 Dec; 108(12):750-68; discussion 769. PubMed ID: 15656086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.
    Mendes HF; van der Spuy J; Chapple JP; Cheetham ME
    Trends Mol Med; 2005 Apr; 11(4):177-85. PubMed ID: 15823756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental therapeutic modalities for retinitis pigmentosa].
    Banin E; Chowers I
    Harefuah; 2004 May; 143(5):368-71, 389. PubMed ID: 15190851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rod and cone opsin mislocalization in an autopsy eye from a carrier of X-linked retinitis pigmentosa with a Gly436Asp mutation in the RPGR gene.
    Adamian M; Pawlyk BS; Hong DH; Berson EL
    Am J Ophthalmol; 2006 Sep; 142(3):515-8. PubMed ID: 16935610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel RPGR exon ORF15 mutation in a family with X-linked retinitis pigmentosa and Coats'-like exudative vasculopathy.
    Demirci FY; Rigatti BW; Mah TS; Gorin MB
    Am J Ophthalmol; 2006 Jan; 141(1):208-10. PubMed ID: 16387007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coexistence of age-related macular degeneration and retinitis pigmentosa in three unrelated families.
    Sarraf D; Salib DM; Jain A; Quiram PA
    Semin Ophthalmol; 2007; 22(3):155-61. PubMed ID: 17763236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The characteristics of retinitis pigmentosa with retinal vascular occlusion].
    Wang GL; Lu N; Zhang F; Peng XY; Li Y; Wang MY
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):414-8. PubMed ID: 15938805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy and retinitis pigmentosa: advances and future challenges.
    Dejneka NS; Bennett J
    Bioessays; 2001 Jul; 23(7):662-8. PubMed ID: 11462220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinitis pigmentosa--an overview.
    Allard RE
    J Am Optom Assoc; 1983 Sep; 54(9):793-800. PubMed ID: 6604745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping retinal degeneration and loss-of-function in Rd-FTL mice.
    Greferath U; Goh HC; Chua PY; Astrand E; O'Brien EE; Fletcher EL; Murphy M
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5955-64. PubMed ID: 19661224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa.
    Murakami T; Akimoto M; Ooto S; Suzuki T; Ikeda H; Kawagoe N; Takahashi M; Yoshimura N
    Am J Ophthalmol; 2008 Apr; 145(4):687-94. PubMed ID: 18242574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental therapeutic modalities for retinitis pigmentosa].
    Chowers I; Banin E
    Harefuah; 2003 Apr; 142(4):277-80, 317. PubMed ID: 12754878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium.
    Radtke ND; Aramant RB; Petry HM; Green PT; Pidwell DJ; Seiler MJ
    Am J Ophthalmol; 2008 Aug; 146(2):172-182. PubMed ID: 18547537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.